Literature DB >> 28731039

Peripheral neuropathies: Long-term opioid therapy in neuropathy: benefit or harm?

Claudia Sommer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28731039     DOI： 10.1038/nrneurol.2017.101

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

Review 1.  The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction.

Authors:  Andrew Kolodny; David T Courtwright; Catherine S Hwang; Peter Kreiner; John L Eadie; Thomas W Clark; G Caleb Alexander
Journal:  Annu Rev Public Health       Date:  2015-01-12       Impact factor: 21.981

Review 2.  Polysubstance use and misuse or abuse of prescription opioid analgesics: a multi-level analysis of international data.

Authors:  Katherine I Morley; Jason A Ferris; Adam R Winstock; Michael T Lynskey
Journal:  Pain       Date:  2017-06       Impact factor: 6.961

3.  The opioid epidemic and the long-term opioid therapy for chronic noncancer pain revisited: a transatlantic perspective.

Authors:  Winfried Häuser; Frank Petzke; Lukas Radbruch; Thomas R Tölle
Journal:  Pain Manag       Date:  2016-03-18

4.  Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.

Authors:  S H Sindrup; G Andersen; C Madsen; T Smith; K Brøsen; T S Jensen
Journal:  Pain       Date:  1999-10       Impact factor: 6.961

5.  Association of Long-term Opioid Therapy With Functional Status, Adverse Outcomes, and Mortality Among Patients With Polyneuropathy.

Authors:  E Matthew Hoffman; James C Watson; Jennifer St Sauver; Nathan P Staff; Christopher J Klein
Journal:  JAMA Neurol       Date:  2017-07-01       Impact factor: 18.302

Review 6.  Provision of Palliative Care in Low- and Middle-Income Countries: Overcoming Obstacles for Effective Treatment Delivery.

Authors:  Breffni Hannon; Camilla Zimmermann; Felicia M Knaul; Richard A Powell; Faith N Mwangi-Powell; Gary Rodin
Journal:  J Clin Oncol       Date:  2015-11-17       Impact factor: 44.544

7.  Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain.

Authors:  S Arnér; B A Meyerson
Journal:  Pain       Date:  1988-04       Impact factor: 6.961

8.  Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.

Authors:  C P Watson; N Babul
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

Review 9.  Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.

Authors:  Nanna B Finnerup; Nadine Attal; Simon Haroutounian; Ewan McNicol; Ralf Baron; Robert H Dworkin; Ian Gilron; Maija Haanpää; Per Hansson; Troels S Jensen; Peter R Kamerman; Karen Lund; Andrew Moore; Srinivasa N Raja; Andrew S C Rice; Michael Rowbotham; Emily Sena; Philip Siddall; Blair H Smith; Mark Wallace
Journal:  Lancet Neurol       Date:  2015-01-07       Impact factor: 44.182

Review 10.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272
  10 in total
  6 in total

1.  Chronic morphine-mediated upregulation of high mobility group box 1 in the spinal cord contributes to analgesic tolerance and hyperalgesia in rats.

Authors:  Junliang Qian; Yanan Zhu; Liying Bai; Yan Gao; Mingjun Jiang; Fei Xing; Jian Zhang; Wenchao Zhao; Hanwen Gu; Yang Mi; Yuan-Xiang Tao; Ji-Tian Xu
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

2.  The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain.

Authors:  Katarzyna Pawlik; Anna Piotrowska; Klaudia Kwiatkowski; Katarzyna Ciapała; Katarzyna Popiolek-Barczyk; Wioletta Makuch; Joanna Mika
Journal:  Immunology       Date:  2020-02-05       Impact factor: 7.397

3.  Blocking of Caveolin-1 Attenuates Morphine-Induced Inflammation, Hyperalgesia, and Analgesic Tolerance via Inhibiting NLRP3 Inflammasome and ERK/c-JUN Pathway.

Authors:  Wenling Liu; Peng Jiang; Liuji Qiu
Journal:  J Mol Neurosci       Date:  2022-03-09       Impact factor: 3.444

4.  Protraction of neuropathic pain by morphine is mediated by spinal damage associated molecular patterns (DAMPs) in male rats.

Authors:  Peter M Grace; Keith A Strand; Erika L Galer; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2017-08-30       Impact factor: 7.217

5.  Oxycodone, fentanyl, and morphine amplify established neuropathic pain in male rats.

Authors:  Suzanne M Green-Fulgham; Jayson B Ball; Andrew J Kwilasz; Timothy Fabisiak; Steven F Maier; Linda R Watkins; Peter M Grace
Journal:  Pain       Date:  2019-11       Impact factor: 7.926

6.  Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.

Authors:  Katarzyna Pawlik; Agata Ciechanowska; Katarzyna Ciapała; Ewelina Rojewska; Wioletta Makuch; Joanna Mika
Journal:  Front Immunol       Date:  2021-11-02       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.